No Added Benefit From Renal-Artery Stenting, Long-Delayed Study Concludes
This article was originally published in The Gray Sheet
Executive Summary
The 947-patient CORAL trial shows renal-artery stenting does not prevent more adverse events than comprehensive medical therapy alone in people with atherosclerotic renal-artery stenosis and hypertension or chronic kidney disease.